top blue
 

 

Empty


Auditorium in new BMEO Building to be named in honor of Thomas Sloan

April 14, 2006
If there were a gene for optics, Thomas R. Sloan would possess it. Five generations of ancestors on his father’s side have been in the optics industry, first in Germany and later in the United States. Sloan recently honored that general heritage and his specific connections to the Institute of Optics with a $1 million donation to the new Optics/BME building. The building’s auditorium will be named after him.

“I’ve been very blessed in life and I’m delighted to be able to give something back to the Institute,” Sloan says. “My family has been involved for generations in optics…primarily optics for vision correction. In a sense, eyeglasses and contact lenses are biomedical-optics appliances—maybe the first such appliances. I’m very excited about this building project and the links it creates between the Institute and biomedical engineering.”

Thomas Sloan in the future Sloan Auditorium

Sloan grew up around optics. In high school he worked in the laboratory of Southern Optical Co., founded by his father Harry Sloan in 1938 when he emigrated to the US to escape the Nazi regime. His father created his company using the training he had obtained at the prestigious Jena University, the home of optics pioneers Karl Zeiss and Ernst Abbe.

Sloan attended Rochester in the 1960s, earning his BS in 1965, and a master’s degree from The Institute in 1967.

“Rochester taught me how to think, and how to solve problems in a strategic sense,” he says.

From UR he went to Boston to work at Itek, pursuing his MBA in the evenings. In 1970 he returned to his roots in Greensboro, North Carolina to join his father’s company. He became president of Southern Optical in 1975. Starting with a sales base of roughly $2 million, over the course of his 30 year career he expanded the business throughout the southeastern US, sold the company at one point while continuing to run it for the new public ownership, and then reacquired it in the late 1980s. In 1996, the company, with sales of about $75 million, was purchased by the French ophthalmics giant Essilor, and Sloan was made head of the newly formed division - Essilor Laboratories of America (sales today over $500 million).

In recent years Sloan has scaled back his efforts at Essilor and has plunged into a variety of entrepreneurial activities for both profit and non-profit entities. He has helped launch a number of health-related startup companies such as Mercury MD and Mediwave Star Technology. He’s also chairman of SterlingSouth Bank and Trust, a bank he helped to form. In addition, he is very active in numerous local community organizations including recent terms on the board of the University of North Carolina at Greensboro and Moses Cone Health System.

“I really enjoy the entrepreneurial challenge of start-up companies and small organizations,” he says. “I don’t use the word ‘retired’ in any sense.”

The picture above shows Thomas Sloan standing in the future Sloan Auditorium.


Text by Steve Braun
Photo by Betsy Benedict

 

©2006 University of Rochester